Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
8638cover_open1a.gif

September 22, 2008 Cover

Volume 86, Issue 38

The already challenging path to an HIV vaccine takes a hard turn after recent clinical trials

Full Article
Volume 86 | Issue 38

All Issues

Biological Chemistry

Resetting Priorities

The already challenging path to an HIV vaccine takes a hard turn after recent clinical trials

  • Near-IR Imaging Goes Further

    New dyes open door to biomedical applications of near-IR imaging

  • Preferred Contracts

    Custom manufacturers of pharmaceutical actives and intermediates vie for a position in new big pharma supply chains

  • Tests Of Endocrine Disruptors Delayed

    After more than a decade, EPA's program has not begun screening a single chemical

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT